Agilent TechnologiesFRA:AG8 -2.35%94 Quick Ratio is 1.62 as of Apr. 2026, which is 5% below its 10-year median of 1.70. GuruFocus rates FRA:AG8 with a GF Score™ of 94/100 and a GF Value™ of €127.52 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 214 Medical Diagnostics & Research companies, Agilent Technologies ranks worse than 51.4% on this metric.
Agilent Technologies has a quick ratio of 1.62. It generally indicates good short-term financial strength.
The historical rank and industry rank for Agilent Technologies's Quick Ratio or its related term are showing as below:
FRA:AG8'
s Quick Ratio Range Over the Past 10 Years
Min: 1.21 Med: 1.7 Max: 3.28
Current: 1.62
During the past 13 years, Agilent Technologies's highest Quick Ratio was 3.28. The lowest was 1.21. And the median was 1.70.
FRA:AG8's Quick Ratio is ranked worse than 51.4% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.715
vs FRA:AG8: 1.62
Agilent Technologies (FRA:AG8) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Agilent Technologies Quick Ratio Related Terms
Agilent Technologies Quick Ratio Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AG8 vs NTRA, WAT, IDXX: Quick Ratio Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Agilent Technologies's Quick Ratio for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies (FRA:AG8) has a Quick Ratio of 1.62 as of Apr. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Agilent Technologies and its competitors. This is near median its historical median of 1.70. Over the past decade, Agilent Technologies' Quick Ratio has ranged from 1.21 to 3.28. According to the industry distribution chart, Agilent Technologies ranks #110 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 51.4%.
Is Agilent Technologies' Quick Ratio too high?
Agilent Technologies' current Quick Ratio of 1.62 is near median its 10-year median of 1.70. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 3.28. The Medical Diagnostics & Research industry median Quick Ratio is 1.72. Agilent Technologies' value of 1.62 is 5.5% below this industry median. Based on the distribution chart, Agilent Technologies ranks #110 out of 214 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Quick Ratio compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #110 out of 214 companies for Quick Ratio. This places Agilent Technologies in the lower half of its industry. The industry median Quick Ratio is 1.72. Agilent Technologies' value of 1.62 is 5.5% below this benchmark. Historically, Agilent Technologies' own Quick Ratio has ranged from 1.21 to 3.28 over the past decade. While the company's 10-year median is 1.70 vs. the industry median of 1.72, Agilent Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.72, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current Quick Ratio of 1.62 is 5.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current Quick Ratio is 1.62, which is near median its own 10-year median of 1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (FRA:AG8) is currently considered Modestly Undervalued. The stock's GF Value™ is €127.52, compared to a current price of €114.50 — trading 10.2% below its estimated fair value. The current Quick Ratio is 1.62, which is near median its 10-year median of 1.70 and 5.5% below the Medical Diagnostics & Research industry median of 1.72. Agilent Technologies' overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Agilent Technologies (FRA:AG8), the current Quick Ratio is 1.62 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (FRA:AG8) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of €114.50 is trading 10.2% below its estimated GF Value™ of €127.52.
GuruFocus considers Agilent Technologies to be Modestly Undervalued.
Key valuation signals for FRA:AG8:
Quick Ratio: 1.62 (near median its 10-year median of 1.70)
GF Value™: €127.52 vs. price of €114.50 (10.2% below fair value)
Industry Position: 5.5% below the Medical Diagnostics & Research median (#110 of 214)
No single metric tells the full story. See the FRA:AG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
94GF Score
Get the complete analysis for FRA:AG8
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AG8 has been successfully added to your 
